-transparent.png){kind=logo}
Recombinant interferon-alpha-2C (rec. IFN alpha-2C) and recombinant interferon-gamma (IFN-gamma) was studied in 12 patients with metastasized renal cell carcinoma. 8 patients were treated with IFN-alpha-2C: 1 patient achieved a complete remission, 2 patients showed mixed responses, and 2 had stabilisation of their disease. In 3 patients progressive disease was observed. IFN-gamma was studied in 4 patients; 2 patients showed stable and 2 progressive disease. Side effects of IFN-alpha treatment included influenza-like symptoms, moderate hematological toxicity and neurological symptoms. During treatment with IFN-gamma similar side effects were observed, although fever generally was more pronounced. All symptoms ceased after dosis reduction or discontinuation of treatment.
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
February 1987,
Onkologie,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
January 1985,
Acta medica Austriaca,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
October 1987,
Journal of hepatology,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
January 1989,
Gynakologische Rundschau,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
January 1993,
Wiener medizinische Wochenschrift (1946),
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
January 1992,
International journal of STD & AIDS,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
August 2005,
Nihon rinsho. Japanese journal of clinical medicine,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
February 1989,
Contact dermatitis,
R Kuzmits, and
W Scheithauer, and
H Ludwig, and
R Flener
December 1987,
Zeitschrift fur Urologie und Nephrologie,
